Results 181 to 190 of about 20,588,866 (381)
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
Access to, and outcome of, renal transplantation according to treatment modality of end-stage renal disease in France [PDF]
Ylana Chalem +5 more
openalex +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland [PDF]
Khalid Al‐Qahtani +5 more
openalex +1 more source
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source
Estimating Expected Individual Treatment Outcomes by Using Nonparametric Evaluation Methods [PDF]
Consider the situation faced by an individual which has to choose among different treatments available to him. For selecting the optimal treatment he needs to conjecture for each treatment how his situation after treatment would likely to be.
Markus Froelich
core
Treatment outcomes of patients with tuberculosis in war affected region of Khyber Pakhtunkhwa, Pakistan [PDF]
Tauseef Ahmad +11 more
openalex +1 more source

